Empowered Funds
LXEO icon

Empowered Funds’s Lexeo Therapeutics LXEO Stock Holding History

Empowered Funds’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$199K Buy
+58,993
New +$267K ﹤0.01% 2258

Other funds holding LXEO

Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Empowered Funds's LXEO Position: Q3 2026 in Review

Empowered Funds opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 58,993 shares worth $199K. The stake represents ﹤0.01% of the portfolio and ranks #2258 among its holdings.

97 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

  • Empowered Funds held 58,993 shares of Lexeo Therapeutics worth $199K as of Q3 2026.
  • Lexeo Therapeutics was a new Empowered Funds position in Q3 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2258 holding.
  • 97 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.